References
- DiestelhorstMLarssonLIEuropean Latanoprost Fixed Combination Study GroupA 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertensionBr J Ophthalmol20048819920314736774
- HamacherTSchinzelMSchölzel-KlattAShort term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapiesBr J Ophthalmol2004881295129815377554
- PoloVLarrosaJMFerrerasABorqueEPabloLEHonrubiaFMEffect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% administered in the evening in glaucomaAnn Ophthalmol200840157162
- DunkerSSchumckerAMaierHLatanoprost/Timolol Fixed Combination Study GroupTolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timololAdv Ther20072437638617565929
- InoueKOkayamaRHigaROcular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combinationJ Ocul Pharmacol Ther20112758158722011049
- BogerWPIIIShort-term “escape” and long-term “drift”: the dissipation effects of the β-adrenergic blocking agentsSurv Ophthalmol1983Suppl 282352426141645
- RigolletJPKOndateuiJAPastoALopLRandomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleateClin Ophthalmol2011518719121383947
- HigginbothamEJFeldmanRStilesMDubinerHFixed Combination Investigative GroupLatanoprost and timolol combination therapy vs monotherapy: one-year randomized trialArch Ophthalmol200212091592212096962
- SchwennOHeckmannBGuzyCMillerPJLong-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional studyBMC Ophthalmol2010102120825668